CLINICAL_TRIALS
trial_result
· 2020-08-03
Clinical Trial Update: Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer [Phase 1]
Summary
Phase 1 trial update reported on pharmacokinetics of doxorubicin used in transarterial chemoembolization (cTACE) for liver cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Liver Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-08-03